Phase 4 and Life Cycle Management
This module is part of the DIA Drug Development and Life Cycle Management eLearning Program. In the Phase 4 and Life Cycle Management module, learners will review typical activities associated with management of a marketed drug, as well as focus on how companies maximize the value of approved products through the lifecycle management process.
Estimated time to complete module: .75 hour/45 minutes
Who should attend?
This module is designed for individuals who are new to, or changing roles, in the pharmaceutical and biotech industries. This module will also benefit professionals who work in the area of:
- Clinical Research
- Project Management
- Administrative Support
- Quality Assurance
- Regulatory Affairs
- Medical Writing
- Business Support
Upon completion of this module, learners should be able to:
- List the key objectives of Phase 4 studies
- Describe the five stages of a product life cycle
- Outline how to grow or maintain market share by capitalizing on product or patient characteristics